Palladium-catalyzed amination of dichloroquinolines with adamantane-containing amines

Article abstract of DOI:10.3390/molecules18022096

Pd-catalyzed amination of isomeric 2,6-, 2,8-, 4,8- and 4,7-dichloroquinolines was studied using adamantane-containing amines in which substituents at the nitrogen atom differ in bulkiness. The selectivity of the amination of 2,6-dichloroquinoline was ver

Full text of DOI:10.3390/molecules18022096

Molecules 2013, 18, 2096-2109; doi:10.3390/molecules18022096
OPEN ACCESS
molecules
ISSN 1420-3049
www.mdpi.com/journal/molecules
Article
Palladium-Catalyzed Amination of Dichloroquinolines with
Adamantane-Containing Amines
Anton S. Abel 1, Alexei D. Averin 1,*, Olga A. Maloshitskaya 1, Evgenii N. Savelyev 2,
Boris S. Orlinson 2, Ivan A. Novakov 2 and Irina P. Beletskaya 1
1
Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory, 1-3,
Moscow 119991, Russia; E-Mails: antonabel@list.ru (A.S.A.); maloshitskaya@mail.ru (O.A.M.);
beletska@org.chem.msu.ru (I.P.B.)
2
Volgograd State Technical University, 28 Lenina prosp., Volgograd 400131, Russia;
E-Mails: phanchem@vstu.ru (E.N.S.; B.S.O.); rector@vstu.ru (I.A.N)
* Author to whom correspondence should be addressed; E-Mail: alexaveron@yandex.ru;
Tel.: +7-495-939-1139; Fax: +7-495-939-3618.
Received: 31 December 2012; in revised form: 24 January 2013 / Accepted: 1 February 2013 /
Published: 6 February 2013
Abstract: Pd-catalyzed amination of isomeric 2,6-, 2,8-, 4,8- and 4,7-dichloroquinolines
was studied using adamantane-containing amines in which substituents at the nitrogen
atom differ in bulkiness. The selectivity of the amination of 2,6-dichloroquinoline was very
low, substantially better results were obtained with 2,8-dichloroquinoline, and 4,8- and
4,7-dichloroquinolines provided the best yields of the amination products. Diamination of
4,8- and 4,7-dichloroquinolines was carried out with two amines which differ strongly in
the bulkiness of the alkyl group. In the majority of cases BINAP ligand was successfully
applied, however, it had to be replaced with DavePhos in certain reactions when using the
most sterically hindered amine as well as for the diamination reactions.
Keywords: amines; adamantane; Pd catalysis; amination; quinoline
1. Introduction
The pharmacological activity of adamantane derivatives is well documented and arises from various
factors, the main being their ability to penetrate the lipid layers of membranes and to interact with
hydrophobic sites of proteins due to the presence of a rigid lipophilic backbone. A special place among

Molecules 2013, 18
2097
these compounds is occupied by the amines with adamantane-containing substituents which have already
found medical applications, like adamantan-1-amine (amantadine) [1], (1-adamantylmethyl)amine
hydrochloride (rimantadine) [2], 1,3-dimethyladamantan-5-amine (memantine) [3]. Biological studies
of the adamantane derivatives bearing heterocyclic substituents, e.g., pyridine, pyrazole, benzimidazole,
and other N-heterocycles are reported [4], and their psychotropic activity was especially addressed.
However, there is scarce information about the quinolinyl derivatives of adamantaneamines, as only
two publications [5,6] deal with 4-quinolinyl derivatives which demonstrated anti-malarial activity,
and one describes the synthesis of 2-quinolinyl-substituted adamantane-1,3-diamine [7]. All these
compounds were obtained using non-catalytic methods.
In general, the successful application of catalytic amination for the synthesis of aminoquinoline
compounds from corresponding halogen derivatives depends strongly on the position of the halogen
atom in the quinoline moiety. Pd-catalyzed amination reactions [8–13] are the most frequently used for
this purpose. There are enough examples of the Pd-catalyzed amination of 2-chloroquinoline [14–18],
3-bromo- and 3-chloroquinolines [13–23], 6-bromoquinoline [24,25]. Less studied are the Pd-catalyzed
aminations of 5-bromoquinoline [26,27], 8-chloro- and 8-bromoquinolines [14,28]. The Cu-catalyzed
amination of 3-haloquinolines [29–31] and of 5-bromoquinoline [32] has also been reported, while
there is almost no information about the application of the catalytic approaches for the synthesis of
4-aminoquinoline derivatives except for one work [33], although 4-amino- and especially 4-amino-7-
chloroquinolines were shown to be potent anti-malarial agents [34–36].
Taking all these facts into consideration and in view of our interest in the Buchwald-Hartwig
amination of heteroaryl halides [37–40], we decided to study the Pd-catalyzed amination reactions of
isomeric dichloroquinolines with selected adamantane-containing amines, which differ in the steric
hindrance at the amino group, and to determine the best conditions for the selective mono- and
diamination of these hetaryl dichlorides.
2. Results and Discussion
We investigated the Pd-catalyzed amination of commercially available 2,6-, 2,8-, 4,8- and
4,7-dichloroquinolines which possess two chlorine atoms of different reactivity. The four adamantane-
containing amines 1a–d studied in the amination reactions have different substituents at the nitrogen
atom. Catalytic reactions were carried out using Pd(dba)2 as a source of Pd(0), phosphine ligands
BINAP (2,2'-bis(diphenylphosphino)-1,1'-binaphthalene) or DavePhos (2-dicyclohexylphosphino-2'-
dimethylaminobiphenyl), and sodium tert-butoxide as a base. The reactions were conducted in boiling
dioxane (c = 0.1 M), equimolar amounts of reagents were employed for the synthesis of
monoaminosubstituted quinolines, 3–4 equiv. of amine were used to obtain diamino-substituted
products. All four amines were studied in the monoamination reactions with each dichloroquinoline,
and two amines, namely 1a and 1d, were employed in the diamination processes. Generally, the
reactions were run for 6–8 h in the case of monoamination processes and 15 h in the case of
diamination processes to achieve full consumption of the starting materials. The reaction products
were isolated by column chromatography on silica gel. First, we carried out the reactions of
2,6-dichloroquinoline which was thought to be suitable for the synthesis of monoaminated products
due to the presence of a reactive chlorine atom in position 2 and a much less reactive chlorine in

Molecules 2013, 18
2098
position 6. However, all our attempts to obtain the monoamino or diamino derivative failed. The
reactions with 1 or 4 equiv. of the amine 1a catalyzed with 4 or 8 mol% of the catalyst, in the presence
of BINAP or DavePhos, provided only complicated reaction mixtures which could not be separated by
the chromatography. Such behavior of 2,6-dichloroquinoline may be explained by a high reactivity of
the chlorine atom at position 2 which promotes the N-arylation and N,N-diarylation reactions as well as
other substitution processes like alkoxylation with t-BuONa and homocoupling. Moreover, the
substitution of the chlorine atom at position 2 markedly affects the substitution of the chlorine atom at
position 6 due to a mesomeric effect. Thus we gave up attempts to work with 2,6-dichloroquinoline and
turned to its isomer, 2,8-dichloroquinoline (Scheme 1).
Scheme 1. Pd-catalyzed amination of 2,8-dichloroquinoline.
This compound also possesses two chlorine atoms with distinctively different reactivity. The
reaction with a less sterically hindered amine 1a catalyzed by 4 mol% catalyst with BINAP as ligand
provided 64% yield of the monoamination product 2a in which a more reactive chlorine atom was
substituted for the amino group (Table 1, entry 1). The attempt to obtain the diamination product by
reacting 2,8-dichloroquinoline with 4 equiv. of the amine 1a in the presence of the twofold amount of
the same catalyst gave rise to an inseparable mixture (entry 2), and the diamination product could not
be isolated as an individual product. The change of BINAP for the electron-donor DavePhos led to the
formation of one main product 3, which is the result of the combination of the diamination and
N,N-diarylation processes (entry 3). It was isolated in 41% yield, and no desired diamino compound
1
was obtained. The H-NMR spectrum of compound 3 is characterized by two distinctively different
NCH2CH2O fragments. The first, bearing two quinolinyl substitutents at the nitrogen atom, possesses
downfield-shifted CH2N protons ( 4.58 ppm), while in the second fragment CH2N protons are
13
observed at 3.4 ppm. In the C-NMR spectrum the corresponding carbon atoms are observed at 49.8
and 43.9 ppm, respectively. To compare, in the compound 2a the protons of the CH2N group are
observed at 3.7 ppm and corresponding carbon atom possesses the chemical shift 42.0 ppm. The

Molecules 2013, 18
2099
downfield shift of both protons and carbon atoms in CH2NQuin2 fragment compared to CH2NHQuin is
very characteristic [40] and verifies the structure of the compound 3. Additional support is provided
by a pronounced downfield shift of the H3, H3' protons of the quinolinyl moieties in compound 3
(7.47 ppm compared to 6.67 ppm in N-monoaryl derivative 2a).
Table 1. Pd-catalyzed amination of 2,8-dichloroquinoline.
Entry Amine Equiv. of amine Ligand Pd(dba)2/L, mol%
Product, yield
2a, 64%
1
2
3
4
5
6
7
8
9
1a
1a
1a
1b
1c
1d
1d
1d
1d
1
4
4
1
1
1
3
1
3
BINAP
BINAP
4/4.5
8/9
inseparable mixture
3, 41%
DavePhos
BINAP
8/9
4/4.5
4/4.5
4/4.5
8/9
2b, 42%; 4, 26%
2c, 56%
BINAP
BINAP
no amination
inseparable mixture
2d, 42%
BINAP
DavePhos
DavePhos
4/4.5
8/9
inseparable mixture
The reaction with one equivalent of a more sterically hindered amine 1b unexpectedly gave not
only the target monoamino derivative 2b, but also some amount of the diamination product 4 (entry 4).
This fact can be explained by the impossibility of N,N-diarylation in this case due to steric hindrances
in the amine 1b. Amine 1c, in which the amino group bears a substituent with a tertiary carbon atom, is
somewhat less active and provided 56% yield of the monoamination product 2c (entry 5). It was
necessary to increase the reaction time to 15 h to ensure full consumption of the starting materials. The
reaction with the most sterically hindered amine 1d could not be catalyzed with 4 mol% catalyst using
BINAP (entry 6), but the application of DavePhos solved the problem, and the target compound 2d
was obtained in 42% yield (entry 8). It was found impossible to synthesize diaminosubstituted
quinoline using the excess of amine and twofold amount of the catalyst either in the presence of
BINAP or DavePhos ligands (entries 7 and 9). In all runs the reaction mixtures contained numerous
compounds which could not be separated by the column chromatography. In many cases the formation
of 2-tert-butoxy-substituted quinolines was noted, due to the non-catalytic substitution of the chlorine
atom, and this process diminished the yields of the target amination products. The most upfield-shifted
proton of the quinoline moiety in the compounds of type 2 ( 6.6–6.7 ppm) possesses the largest
coupling constant (3J = 8.8 Hz) with the most downfield-shifted proton ( 7.7–7.8 ppm). This fact
unambiguously supports the structure of these compounds with the amino group in position 2 of the
3
quinoline system because JH3H4 is the largest coupling constant in quinolines and the difference in
chemical shifts of these protons in 2-aminoquinolines is the biggest.
If 2,8-dichloroquinoline was found to be quite capricious in the Pd-catalyzed amination, its isomer,
4,8-dichloroquinoline, proved to react in a smoother manner (Scheme 2). The reaction of the most
active amine 1a under the convenient catalytic conditions provided 77% yield of the product of the
compound 5a (Table 2, entry 1). It was impossible to obtain the 4,8-diaminosubstituted quinoline 6a
with 4 equiv. of this amine using BINAP as a ligand (entry 2), however, the application of DavePhos
promoted this reaction (entry 3). The monoamination processes ran normally for all other amines 1b–d
and the yields of the 4-amino-8-chloroquinolines ranged from 67 to 84% (entries 4–6). These better

Molecules 2013, 18
2100
results compared to the reactions with 2,8-dichloroquinoline can be attributed to a lower reactivity of
the chlorine atom in the position 4 due to steric reasons and to the absence of the possible side
reactions like N,N-diarylation. These results are in a good correspondence with our recent observations
of the catalytic amination of 2- and 4-chloroquinolines [40]. The diamination of 4,8-dichloroquinoline
with the most hindered amine 1d is possible when using DavePhos ligand (entry 8), whereas in the
presence of BINAP the reaction gave only the monoamination product 5d almost in the same yield as
it was with one equivalent of amine 1d (entry 7). The most upfield-shifted proton of the quinoline
moiety in the compounds of type 5 ( 6.2–6.5 ppm) possesses the smallest coupling constant (3J = 5.4 Hz)
with the most downfield-shifted proton ( 8.4–8.6 ppm). This fact unambiguously supports the
structure of these compounds with the amino group in the position 4 of the quinoline system because
3JH2H3 is the smallest coupling constant in quinolines and the difference in chemical shifts of these
protons in 4-aminoquinolines is the biggest. The same observation is true for the compounds of type 7
(vide infra).
Scheme 2. Pd-catalyzed amination of 4,8-dichloroquinoline.
Table 2. Pd-catalyzed amination of 4,8-dichloroquinoline.
Entry Amine Equiv. of amine Ligand Pd(dba)2/L, mol%
Product, yield
5a, 77%
1
2
3
4
5
6
7
8
1a
1a
1a
1b
1c
1d
1d
1d
1
4
4
1
1
1
3
3
BINAP
BINAP
4/4.5
8/9
inseparable mixture
6a, 52% a
DavePhos
BINAP
8/9
4/4.5
4/4.5
4/4.5
8/9
5b, 67%
BINAP
5c, 84%
BINAP
5d, 70%
BINAP
5d, 68%
DavePhos
a Contains admixtures.
8/9
6d, 45%
As it has been already mentioned, the halogen atom in the position 7 of the quinoline ring is much
less active than those in the positions 2 and 4, what should result in a better selectivity of the
monoamination process. The reactions of 4,7-dichloroquinoline supported this idea (Scheme 3). The
reaction with the amine 1a afforded 52% yield of the 4-amino-7-chloroquinoline 7a (Table 3, entry 1),
while the diamination process was successful with either BINAP or DavePhos ligands (entries 2 and 3)
providing almost equal amounts of the diaminated product 8a. The reactions with the amines 1b–d were
successful as well, giving corresponding monoaminated products 7b–d in 61–79% yields (entries 4–6).

Molecules 2013, 18
2101
Diamination in the presence of Pd(dba)2/BINAP system ran normally, even with the most bulky amine
1d, affording diamino derivative 8d in 58% yield (entry 7). Diamino-substituted quinolines 6d and 8d
are formed as pairs of diastereomers due to the presence of an asymmetric carbon atom in the structure
of parent amine 1d. Nevertheless, their 1H and 13C spectra show almost no splitting of the signals due
to a long distance between the substituents bearing asymmetric carbon atom, their free rotation and the
presence of a planar heteroaromatic spacer.
Scheme 3. Pd-catalyzed amination of 4,7-dichloroquinoline.
Table 3. Pd-catalyzed amination of 4,7-dichloroquinoline.
Entry Amine Equiv. of amine Ligand Pd(dba)2/L, mol% Product, yield
1
2
3
4
5
6
7
1a
1a
1a
1b
1c
1d
1d
1
4
4
1
1
1
3
BINAP
BINAP
DavePhos
BINAP
BINAP
BINAP
BINAP
4/4.5
8/9
7a, 52%
8a, 67%
8a, 71%
7b, 61%
7c, 79%
7d, 77%
8d, 58%
8/9
4/4.5
4/4.5
4/4.5
8/9
3. Experimental
General
NMR spectra were registered using a Bruker Avance 400 spectrometer, MALDI-TOF spectra were
obtained with a Bruker Autoflex II spectrometer using 1,8,9-trihydroxyanthracene as a matrix
and PEGs as internal standards. Isomeric dichloroquinolines, BINAP and DavePhos ligands, sodium
tert-butoxide were purchased from Aldrich and Acros and used without further purification. Amine 1a
was obtained according to a reported procedure [41], as was amine 1b [42], while amines 1c,d were
obtained according to a method described in ref. [43]. Pd(dba)2 was synthesized from PdCl2 according to
a known procedure [44]. Dioxane was distilled over NaOH followed by the distillation over sodium under
argon. Acetonitrile, dichloromethane and methanol were used freshly distilled.
Palladium-Catalyzed Amination of Dichloroquinolines—General Method
A two-neck flask equipped with a condenser and a magnetic stirrer, flushed with dry argon, was
charged with corresponding dichloroquinoline (50 mg, 0.25 mmol), Pd(dba)2 (6–12 mg, 4–8 mol%),
BINAP or DavePhos ligand (4.5–9 mol%), and absolute dioxane (2 mL). The mixture was stirred for

Molecules 2013, 18
2102
2–3 min, then corresponding amine 1a–d (0.25 or 0.75–1 mmol) and tBuONa (0.375 mmol or 0.75 mmol)
were added, and the reaction mixture was refluxed for 6–15 h. After cooling it down to ambient
temperature the reaction mixture was diluted with CH2Cl2, the solution filtered and evaporated
in vacuo, and the residue was chromatographed on silica gel using a sequence of eluents: petrol ether,
petrol ether–CH2Cl2 2:1–1:1, CH2Cl2, CH2Cl2/MeOH 200:1–3:1.
N-[2-(1-Adamantyloxy)ethyl]-8-chloroquinolin-2-amine (2a). Obtained from 2,8-dichloroquinoline
(50 mg), amine 1a (49 mg) in the presence of Pd(dba)2 (6 mg), BINAP (7 mg) and t-BuONa (36 mg).
Eluent CH2Cl2/MeOH 100:1. Yield 57 mg (64%), yellowish viscous oil. 1H-NMR (CDCl3)  1.55–1.68
(m, 6H), 1.76 (br.s, 6H), 2.14 (br.s, 3H), 3.66–3.70 (m, 2H), 3.70–3.75 (m, 2H), 5.27 (br.s, 1H), 6.67
(d, J = 8.7 Hz, 1H), 7.08 (dd, Jobs = 7.7, 7.7 Hz, 1H), 7.47 (d, J = 7.8 Hz, 1H), 7.62 (d, J = 7.5 Hz, 1H),
13
7.76 (d, J = 8.7 Hz, 1H). C-NMR (CDCl3) 30.5 (3C), 36.4 (3C), 41.6 (3C), 42.0 (1C), 58.7 (1C),
72.4 (1C), 112.6 (1C), 121.5 (1C), 124.5 (1C), 126.4 (1C), 129.5 (1C), 129.9 (1C), 137.3 (1C), 157.1
(1C), one quaternary carbon atom was not assigned due to line broadening. HRMS (MALDI-TOF):
C21H26ClN2O (M+H)+ calcd.; 357.1734 observed; 357.1769.
N2,N8-bis[2-(1-Adamantyloxy)ethyl]-N2-(8-{[2-(1-adamantyloxy)ethyl]amino}quinolin-2-yl)quinoline-
2,8-diamine (3). Obtained from 2,8-dichloroquinoline (50 mg), amine 1a (195 mg) in the presence of
Pd(dba)2 (12 mg), DavePhos (9 mg) and t-BuONa (60 mg). Eluent CH2Cl2/MeOH 200:1–100:1. Yield
1
57 mg (64%), yellowish viscous oil. H-NMR (CDCl3)  1.47–1.78 (m, 36H), 2.06 (br.s, 6H), 2.14
(br.s, 3H), 3.38–3.44 (m, 4H), 3.69 (t, J = 5.9 Hz, 4H), 3.84 (t, J = 6.0 Hz, 2H), 4.58 (t, J = 6.0 Hz,
2H), 6.09 (br.s, 2H), 6.67 (d, J = 7.6 Hz, 1H), 6.96 (d, J = 7.3 Hz, 1H), 7.21 (dd, Jobs = 7.8, 7.8 Hz,
1H), 7.47 (d, J = 9.0 Hz, 1H), 7.87 (d, J = 9.0 Hz, 1H). 13C-NMR (CDCl3)  30.4 (9C), 36.4 (9C), 41.5
(9C), 43.9 (2C), 49.8 (1C), 58.0 (1C), 58.5 (2C), 72.2 (2C), 72.3 (1C), 105.4 (1C), 113.8 (1C), 116.4
(1C), 125.0 (1C), 125.5 (1C), 136.4 (1C), 137.0 (1C), 143.8 (1C), 153.9 (1C). HRMS (MALDI-TOF):
C54H70N5O3 (M+H)+ calcd.; 836.5479 observed; 836.5422.
N-(1-Adamantylmethyl)-8-chloroquinolin-2-amine (2b). Obtained from 2,8-dichloroquinoline (50 mg),
amine 1b (41 mg) in the presence of Pd(dba)2 (6 mg), BINAP (7 mg) and t-BuONa (36 mg). Eluent
petroleum ether–CH2Cl2 1:1. Yield 34 mg (42%), yellowish viscous oil. 1H-NMR (CDCl3)  1.58–1.62
(m, 6H), 1.62–1.75 (m, 6H), 1.99 (br.s, 3H), 3.23 (d, J = 5.6 Hz, 2H), 5.03 (br.s, 1H), 6.70 (d, J = 8.8 Hz,
1H), 7.06 (dd, Jobs = 7.7, 7.7 Hz, 1H), 7.46 (d, J = 8.0 Hz, 1H), 7.62 (d, J = 7.5 Hz, 1H), 7.78 (d,
13
J = 8.8 Hz, 1H). C-NMR (CDCl3) 28.3 (3C), 34.2 (1C), 37.0 (3C), 40.5 (3C), 53.4 (1C), 111.5
(1C), 121.3 (1C), 124.4 (1C), 126.3 (1C), 129.6 (2C), 137.5 (1C), 143.5 (1C), 158.0 (1C). HRMS
(MALDI-TOF): C20H24ClN2 (M+H)+ calcd.; 327.1628 observed; 327.1602.
N,N'-bis(1-adamantylmethyl)quinoline-2,8-diamine (4). Obtained as the second product in the synthesis
of compound 2b. Eluent petroleum ether–CH2Cl2 1:1. Yield 16 mg (26%), yellowish viscous oil.
1H-NMR (CDCl3)  1.59–1.79 (m, 24H), 1.98 (br.s, 3H), 2.03 (br.s, 3H), 2.95 (d, J = 5.3 Hz, 2H), 3.28
(d, J = 6.4 Hz, 2H), 4.66 (br.s, 1H), 5.97 (br.s, 1H), 6.54–6.61 (m, 2H), 6.83 (d, J = 8.0 Hz, 1H), 7.05
13
(dd, Jobs = 7.5, 7.5 Hz, 1H), 7.69 (d, J = 8.6 Hz, 1H). C-NMR (CDCl3) С 28.5 (3С), 34.0
(1C), 34.7 (1C), 37.1 (3C), 37.2 (3C), 40.8 (3C), 40.9 (3C), 53.1 (1C), 55.9 (1C), 105.0 (1C), 111.4

Molecules 2013, 18
2103
(1C), 113.4 (1C), 121.3 (1C), 122.6 (1C), 137.5 (1C), 143.2 (1C), 144.3 (1C), 155.5 (1C). HRMS
(MALDI-TOF): C31H42N3 (M+H)+ calcd.; 456.3379 observed; 456.3425.
N-[2-(1-Adamantyl)-1-methylethyl]-8-chloroquinolin-2-amine (2c). Obtained from 2,8-dichloroquinoline
(50 mg), amine 1c (49 mg) in the presence of Pd(dba)2 (6 mg), BINAP (7 mg) and t-BuONa (36 mg).
Eluent petroluem ether–CH2Cl2 2:1–1:1. Yield 52 mg (56%), yellowish viscous oil. 1H-NMR (CDCl3)
 1.27 (d, J = 6.4 Hz, 3H), 1.30 (dd, J = 14.4, 4.2 Hz, 1H), 1.39 (dd, J = 14.4, 7.3 Hz, 1H), 1.54–1.69
(m, 12H), 1.92 (br.s, 3H), 4.33 (br.s, 1H), 4.71 (br.s, 1H), 6.62 (d, J = 8.8 Hz, 1H), 7.06 (dd, Jobs = 7.7,
7.7 Hz, 1H), 7.45 (dd, J = 7.8, 1.0 Hz, 1H), 7.62 (dd, J = 7.5, 1.0 Hz, 1H), 7.77 (d, J = 8.8 Hz, 1H).
13C-NMR (CDCl3) 23.7 (1C), 28.6 (3C), 32.5 (1C), 37.0 (3C), 42.9 (4C), 52.8 (1C), 111.7 (1C),
121.2 (1C), 124.3 (1C), 126.3 (1C), 129.5 (1C), 129.9 (1C), 137.4 (1C), 156.2 (1C), one quaternary
carbon atom was not assigned due to line broadening. HRMS (MALDI-TOF): C22H28ClN2 (M+H)+
calcd.; 355.1941 observed; 355.1917.
N-[1-Adamantyl(phenyl)methyl]-8-chloroquinolin-2-amine (2d). Obtained from 2,8-dichloroquinoline
(50 mg), amine 1d (60 mg) in the presence of Pd(dba)2 (6 mg), DavePhos (5 mg) and t-BuONa (30 mg).
1
Eluent petroleum ether–CH2Cl2 2:1. Yield 42 mg (42%), yellowish viscous oil. H-NMR (CDCl3) 
1.52–1.62 (m, 6H), 1.63–1.72 (m, 3H), 1.72–1.80 (m, 3H), 2.00 (br.s, 3H), 4.52 (br.s, 1H), 5.77 (br.s,
1H), 6.57 (d, J = 8.8 Hz, 1H), 7.03 (dd, Jobs = 7.7, 7.7 Hz, 1H), 7.16–7.33 (m, 5H), 7.40 (d, J = 7.3 Hz,
1H), 7.59 (d, J = 7.3 Hz, 1H), 7.68 (d, J = 8.8 Hz, 1H). 13C-NMR (CDCl3) 28.4 (3C), 36.5 (1C), 36.8
(3C), 39.2 (3C), 66.0 (1C), 110.9 (1C), 121.4 (1C), 124.5 (1C), 126.3 (1C), 126.9 (1C), 127.6 (2C),
128.8 (2C), 129.2 (1C), 129.5 (1C), 137.6 (1C), 139.8 (1C), 144.3 (1C), 154.4 (1C). HRMS (MALDI-
TOF): C26H28ClN2 (M+H)+ calcd.; 403.1941 observed; 403.1960.
N-[2-(1-Adamantyloxy)ethyl]-8-chloroquinolin-4-amine (5a). Obtained from 4,8-dichloroquinoline (50 mg),
amine 1a (49 mg) in the presence of Pd(dba)2 (6 mg), BINAP (7 mg) and t-BuONa (36 mg). Eluent
CH2Cl2/MeOH 100:1–50:1. Yield 69 mg (77%), beige crystalline powder, m.p. 225–227 °C. 1H-NMR
(CDCl3)  1.55–1.68 (m, 6H), 1.74–1.77 (m, 6H), 2.15 (br.s, 3H), 3.40 (q, J = 5.1 Hz, 2H), 3.73 (t,
J = 5.2 Hz, 2H), 5.56 (br.s, 1H), 6.45 (d, J = 5.4 Hz, 1H), 7.31 (dd, Jobs = 8.0, 8.0 Hz, 1H), 7.64 (d,
13
J = 8.5 Hz, 1H), 7.74 (d, J = 7.5 Hz, 1H), 8.64 (d, J = 5.4 Hz, 1H). C-NMR (CDCl3) 30.4 (3C),
36.3 (3C), 41.6 (3C), 43.4 (1C), 57.5 (1C), 72.8 (1C), 99.7 (1C), 118.5 (1C), 120.2 (1C), 124.1 (1C),
129.2 (1C), 133.8 (1C), 144.8 (1C), 150.1 (1C), 151.4 (1C). HRMS (MALDI-TOF): C21H26ClN2O
(M+H)+ calcd.; 357.1734 observed; 357.1698.
N,N'-bis[2-(1-Adamantyloxy)ethyl]quinoline-4,8-diamine (6a). Obtained from 4,8-dichloroquinoline
(50 mg), amine 1a (195 mg) in the presence of Pd(dba)2 (12 mg), DavePhos (9 mg) and t-BuONa (60 mg).
Eluent CH2Cl2/MeOH 50:1. Yield 68 mg (52%), yellowish viscous oil. 1H-NMR (CDCl3)  1.55–1.75
(m, 12H), 1.77 (br.s, 12H), 2.13 (br.s, 3H), 2.16 (br.s, 3H), 3.37–3.46 (m, 4H), 3.73 (t, J = 5.8 Hz, 4H),
5.44 (br.s, 1H), 5.58 (br.s, 1H), 6.41 (d, J = 5.3 Hz, 1H), 6.67 (d, J = 7.7 Hz, 1H), 6.90 (d, J = 8.5 Hz,
1H), 7.27 (dd, Jobs = 8.1, 8.1 Hz, 1H), 8.37 (d, J = 5.3 Hz, 1H). HRMS (MALDI-TOF): C33H46N3O2
(M+H)+ calcd.; 516.3590 observed; 516.3561.

Molecules 2013, 18
2104
N-(1-Adamantylmethyl)-8-chloroquinolin-4-amine (5b). Obtained from 4,8-dichloroquinoline (50 mg),
amine 1b (41 mg) in the presence of Pd(dba)2 (6 mg), BINAP (7 mg) and t-BuONa (36 mg). Eluent
1
CH2Cl2/MeOH 100:1. Yield 56 mg (67%), beige crystalline powder, m.p. 210–212 °C. H-NMR
(CDCl3)  1.58–1.61 (m, 6H), 1.61–1.76 (m, 6H), 2.00 (br.s, 3H), 2.69 (d, J = 5.7 Hz, 2H), 5.11 (t,
J = 5.7 Hz, 1H), 6.47 (d, J = 5.4 Hz, 1H), 7.27 (dd, J = 8.6, 7.6 Hz, 1H), 7.63 (dd, J = 8.6, 1.1 Hz, 1H),
7.71 (dd, J = 7.6, 1.1 Hz, 1H), 8.60 (d, J = 5.4 Hz, 1H). 13C-NMR (CDCl3) 28.1 (3C), 34.0 (1C), 36.8
(3C), 40.6 (3C), 55.0 (1C), 99.4 (1C), 118.2 (1C), 119.9 (1C), 123.9 (1C), 129.1 (1C), 133.9 (1C),
144.8 (1C), 150.5 (1C), 151.4 (1C). HRMS (MALDI-TOF): C20H24ClN2 (M+H)+ calcd.; 327.1628
observed; 327.1654.
N-[2-(1-adamantyl)-1-methylethyl]-8-chloroquinolin-4-amine (5c). Obtained from 4,8-dichloroquinoline
(50 mg), amine 1c (49 mg) in the presence of Pd(dba)2 (6 mg), BINAP (7 mg) and t-BuONa (36 mg).
1
Eluent CH2Cl2/MeOH 100:1–50:1. Yield 75 mg (84%), yellowish viscous oil. H-NMR (CDCl3) 
1.25 (d, J = 6.4 Hz, 3H), 1.38 (dd, J = 14.6, 3.9 Hz, 1H), 1.45 (dd, J = 14.6, 7.6 Hz, 1H), 1.53 (br.s,
6H), 1.54–1.67 (m, 6H), 1.90 (br.s, 3H), 3.78–3.87 (m, 1H), 4.85 (d, J = 7.3 Hz, 1H), 6.48 (d, J = 5.5 Hz,
1H), 7.28 (dd, J = 8.6, 7.5 Hz, 1H), 7.60 (dd, J = 8.6, 1.1 Hz, 1H), 7.72 (dd, J = 7.5, 1.1 Hz, 1H), 8.64
13
(d, J = 5.5 Hz, 1H). C-NMR (CDCl3) 22.4 (1C), 28.5 (3C), 32.5 (1C), 36.8 (3C), 42.9 (3C), 44.2
(1C), 52.6 (1C), 99.2 (1C), 118.2 (1C), 120.0 (1C), 124.0 (1C), 129.2 (1C), 133.8 (1C), 145.0 (1C),
148.5 (1C), 151.4 (1C). HRMS (MALDI-TOF): C22H28ClN2 (M+H)+ calcd.; 355.1941 observed; 355.1978.
N-[1-Adamantyl(phenyl)methyl]-8-chloroquinolin-4-amine (5d). Obtained from 4,8-dichloroquinoline
(50 mg), amine 1d (60 mg) in the presence of Pd(dba)2 (6 mg), BINAP (7 mg) and t-BuONa (36 mg).
Eluent CH2Cl2/MeOH 100:1. Yield 70 mg (70%), beige crystalline powder, m.p. 171–173 °C. 1H-NMR
(CDCl3)  1.55–1.67 (m, 6H), 1.68–1.81 (m, 6H), 2.04 (br.s, 3H), 4.08 (d, J = 6.2 Hz, 1H), 5.77 (d,
J = 6.2 Hz, 1H), 6.19 (d, J = 5.4 Hz, 1H), 7.20–7.32 (m, 5H), 7.38 (dd, Jobs = 7.9, 7.9 Hz, 1H), 7.76 (d,
13
J = 7.6 Hz, 1H), 7.79 (d, J = 8.3 Hz, 1H), 8.44 (d, J = 5.4 Hz, 1H). C-NMR (CDCl3) 28.2 (3C),
36.5 (1C), 36.7 (3C), 39.3 (3C), 67.2 (1C), 100.9 (1C), 117.7 (1C), 120.2 (1C), 124.2 (1C), 127.4 (1C),
127.9 (2C), 128.3 (2C), 129.1 (1C), 134.1 (1C), 137.9 (1C), 144.7 (1C), 149.0 (1C), 151.3 (1C).
HRMS (MALDI-TOF): C26H28ClN2 (M+H)+ calcd.; 403.1941 observed; 403.1930.
N,N'-bis[1-Adamantyl(phenyl)methyl]quinoline-4,8-diamine (6d). Obtained from 4,8-dichloroquinoline
(50 mg), amine 1d (180 mg) in the presence of Pd(dba)2 (12 mg), DavePhos (9 mg) and t-BuONa
(72 mg). Eluent petroleum ether–CH2Cl2 1:1. Yield 75 mg (45%), beige crystalline powder, m.p.
175–177 °C. 1H-NMR (CDCl3)  1.50–1.83 (m, 24H), 1.95–2.04 (m, 6H), 4.00 (d, J = 6.6 Hz) + 4.02
(d, J = 6.7 Hz) (1H for two diastereomers), 4.06 (d, J = 5.0 Hz, 1H), 5.59 (d, J = 5.2 Hz, 1H), 6.11 (d,
J = 5.2 Hz, 1H), 6.27 (d, J = 7.5 Hz, 1H), 6.91 (d, J = 8.3 Hz, 1H), 7.06–7.35 (m, 12H), 8.22 (d,
J = 5.2 Hz, 1H). 13C-NMR (CDCl3)  28.3 (3C), 28.5 (3C), 36.6 (1C), 36.7 (1C), 36.8 (3C), 37.0 (3C),
39.3 (6C), 67.1 (1C), 67.8 (1C), 100.4 + 100.5 (1C for two diastereomers), 103.9 (1C), 105.0 (1C),
125.7 (1C), 126.6 (1C), 127.1 (1C), 127.4 (2C), 127.8 (2C), 128.4 (2C), 128.8 (2C), 138.1 (1C), 138.7
(1C), 140.3 (1C), 144.9 (1C), 145.0 (1C), 147.4 (1C), 148.7 (1C). HRMS (MALDI-TOF): C43H50N3
(M+H)+ calcd.; 608.4005 observed; 608.3969.

Molecules 2013, 18
2105
N-[2-(1-adamantyloxy)ethyl]-7-chloroquinolin-4-amine (7a). Obtained from 4,7-dichloroquinoline (50 mg),
amine 1a (49 mg) in the presence of Pd(dba)2 (6 mg), BINAP (7 mg) and t-BuONa (36 mg). Eluent
1
CH2Cl2/MeOH 50:1–35:1. Yield 46 mg (52%), beige crystalline powder, m.p. 173–175 °C. H-NMR
(CDCl3)  1.55–1.67 (m, 6H), 1.74–1.77 (m, 6H), 2.15 (br.s, 3H), 3.39 (q, J = 5.1 Hz, 2H), 3.72 (t,
J = 5.2 Hz, 2H), 5.54 (br.s, 1H), 6.38 (d, J = 5.3 Hz, 1H), 7.35 (dd, J = 9.0, 2.2 Hz, 1H), 7.64 (d,
13
J = 9.0 Hz, 1H), 7.93 (d, J = 2.2 Hz, 1H), 8.50 (d, J = 5.3 Hz, 1H). C-NMR (CDCl3)  30.4 (3C),
36.3 (3C), 41.6 (3C), 43.3 (1C), 57.6 (1C), 72.8 (1C), 99.2 (1C), 117.3 (1C), 121.0 (1C), 125.3 (1C),
128.6 (1C), 134.8 (1C), 149.0 (1C), 149.9 (1C), 151.9 (1C). HRMS (MALDI-TOF): C21H26ClN2O
(M+H)+ calcd.; 357.1734 observed; 357.1715.
N,N'-bis[2-(1-Adamantyloxy)ethyl]quinoline-4,7-diamine (8a). Obtained from 4,7-dichloroquinoline
(50 mg), amine 1a (195 mg) in the presence of Pd(dba)2 (12 mg), DavePhos (9 mg) and t-BuONa (60 mg).
Eluent CH2Cl2/MeOH 20:1–3:1. Yield 92 mg (71%), beige crystalline powder, m.p. 160–162 °C.
1H-NMR (CDCl3)  1.53–1.66 (m, 12H), 1.72 (br.s, 12H), 2.12 (br.s, 6H), 3.31 (q, J = 4.5 Hz, 2H), 3.42
(q, J = 5.1 Hz, 2H), 3.63 (t, J = 5.0 Hz, 2H), 3.70 (t, J = 5.4 Hz, 2H), 4.59 (br.s, 1H), 6.16 (br.s, 1H),
6.22 (d, J = 5.9 Hz, 1H), 6.79 (dd, J = 9.0, 1.9 Hz, 1H), 6.94 (d, J = 1.9 Hz, 1H), 7.62 (d, J = 9.0 Hz,
13
1H), 8.21 (d, J = 5.9 Hz, 1H). C-NMR (CDCl3) 30.4 (6C), 36.3 (6C), 41.5 (6C), 43.4 (1C), 43.9
(1C), 57.9 (2C), 72.4 (1C), 72.7 (1C), 99.7 (1C), 104.0 (1C), 110.6 (1C), 116.4 (1C), 121.0 (1C), 148.0
(1C), 148.1 (1C), 149.6 (1C), 151.2 (1C). HRMS (MALDI-TOF): C33H46N3O2 (M+H)+ calcd.;
516.3590 observed; 516.3634.
N-(1-Adamantylmethyl)-7-chloroquinolin-4-amine (7b). Obtained from 4,7-dichloroquinoline (50 mg),
amine 1b (41 mg) in the presence of Pd(dba)2 (6 mg), BINAP (7 mg) and t-BuONa (36 mg). Eluent
CH2Cl2/MeOH 100:1–50:1. Yield 50 mg (61%), beige crystalline powder, m.p. 225–227 °C. 1H-NMR
(CD3OD)  1.65 (br.s, 6H), 1.65–1.78 (m, 6H), 1.97 (br.s, 3H), 3.09 (s, 2H), 6.60 (d, J = 5.8 Hz, 1H),
7.39 (dd, J = 9.0, 2.1 Hz, 1H), 7.76 (d, J = 2.1 Hz, 1H), 8.13 (d, J = 9.0 Hz, 1H), 8.30 (d,
J = 5.8 Hz, 1H), NH proton was not observed. 13C-NMR (CD3OD) 29.8 (3C), 36.7 (1C), 38.0 (3C),
41.7 (3C), 55.5 (1C), 100.0 (1C), 118.6 (1C), 124.2 (1C), 125.9 (1C), 127.5 (1C), 136.3 (1C), 149.7 (1C),
152.2 (1C), 153.8 (1C). HRMS (MALDI-TOF): C20H24ClN2 (M+H)+ calcd.; 327.1628 observed; 327.1649.
N-[2-(1-Adamantyl)-1-methylethyl]-7-chloroquinolin-4-amine (7c). Obtained from 4,7-dichloroquinoline
(50 mg), amine 1c (49 mg) in the presence of Pd(dba)2 (6 mg), BINAP (7 mg) and t-BuONa (36 mg).
Eluent CH2Cl2/MeOH 50:1. Yield 73 mg (79%), beige crystalline powder, m.p. 207–209 °C. 1H-NMR
(CDCl3)  1.26 (d, J = 6.2 Hz, 3H), 1.39 (dd, J = 14.8, 3.9 Hz, 1H), 1.46 (dd, J = 14.8, 7.6 Hz, 1H), 1.54
(br.s, 6H), 1.54–1.69 (m, 6H), 1.91 (br.s, 3H), 3.78–3.87 (m, 1H), 4.78 (d, J = 7.2 Hz, 1H), 6.42 (d,
J = 5.5 Hz, 1H), 7.33 (dd, J = 9.1, 2.2 Hz, 1H), 7.60 (d, J = 9.1 Hz, 1H), 7.93 (d, J = 2.2 Hz, 1H), 8.51
13
(d, J = 5.5 Hz, 1H). C-NMR (CDCl3) 22.4 (1C), 28.5 (3C), 32.5 (1C), 36.8 (3C), 43.0 (3C), 44.1
(1C), 52.6 (1C), 98.8 (1C), 117.2 (1C), 120.7 (1C), 125.1 (1C), 128.8 (1C), 134.8 (1C), 148.2 (1C), 149.3
(1C), 152.0 (1C). HRMS (MALDI-TOF): C22H28ClN2 (M+H)+ calcd.; 355.1941 observed; 355.1904.
N-[1-Adamantyl(phenyl)methyl]-7-chloroquinolin-4-amine (7d). Obtained from 4,7-dichloroquinoline
(50 mg), amine 1d (60 mg) in the presence of Pd(dba)2 (6 mg), BINAP (7 mg) and t-BuONa (36 mg).
Eluent CH2Cl2/MeOH 100:1. Yield 77 mg (77%), yellowish viscous oil. 1H-NMR (CDCl3)  1.54–1.66

Molecules 2013, 18
2106
(m, 6H), 1.68–1.80 (m, 6H), 2.03 (br.s, 3H), 4.07 (d, J = 6.2 Hz, 1H), 5.70 (d, J = 6.2 Hz, 1H), 6.13 (d,
J = 5.3 Hz, 1H), 7.23–7.33 (m, 5H), 7.41 (dd, J = 8.8, 1.9 Hz, 1H), 7.79 (d, J = 8.8 Hz, 1H), 7.93 (d,
13
J = 1.9 Hz, 1H), 8.31 (d, J = 5.3 Hz, 1H). C-NMR (CDCl3) 28.2 (3C), 36.5 (1C), 36.7 (3C), 39.3
(3C), 67.1 (1C), 100.4 (1C), 117.4 (1C), 120.4 (1C), 125.3 (1C), 127.4 (1C), 127.9 (2C), 128.7 (2C),
129.0 (1C), 134.6 (1C), 138.0 (1C), 148.7 (1C), 148.9 (1C), 151.9 (1C). HRMS (MALDI-TOF):
C26H28ClN2 (M+H)+ calcd.; 403.1941 observed; 403.1958.
N,N'-bis[1-Adamantyl(phenyl)methyl]quinoline-4,7-diamine (8d). Obtained from 4,7-dichloroquinoline
(50 mg), amine 1d (180 mg) in the presence of Pd(dba)2 (12 mg), BINAP (14 mg) and t-BuONa
(72 mg). Eluent CH2Cl2/MeOH 35:20:1. Yield 88 mg (58%), beige crystalline powder, m.p. 240–242 °C.
1H-NMR (CDCl3)  1.48–1.63 (m, 12H), 1.63–1.76 (m, 12H), 1.99 (br.s, 6H), 4.00–4.06 (2H), 4.74 (d,
J = 6.7 Hz, 1H), 5.54 (d, J = 6.1 Hz), 5.85 (d, J = 5.4 Hz) + 5.86 (d, J = 5.4 Hz) (1H for two
diastereomers), 6.81 (br.s, 1H), 6.85 (d, J = 9.0 Hz, 1H), 7.14–7.28 (m, 10H), 7.56 (d, J = 9.0 Hz, 1H),
13
8.07 (d, J = 5.4 Hz, 1H). C-NMR (CDCl3) 28.3 (3C), 28.4 (3C), 36.5 (2C), 36.8 (3C), 36.8 (3C),
39.2 (3C), 39.3 (3C), 66.9 (1C), 67.6 (1C), 97.1 + 97.8 (1C for two diastereomers), 107.1 (1C), 111.0
(1C), 115.7 (1C), 119.6 (1C), 126.9 (1C), 127.2 (1C), 127.7 (2C), 127.8 (2C), 128.3 (2C), 128.6 (2C),
138.5 (1C), 138.6 (1C), 139.5 (1C), 148.4 (1C), 149.1 (1C), 150.3 (1C). HRMS (MALDI-TOF):
C43H50N3 (M+H)+ calcd.; 608.4005 observed; 608.3980.
4. Conclusions
To sum up, we have investigated the Pd-catalyzed amination reactions of isomeric chloroquinolines
with several adamantane-containing amines and found out that 4,8- and 4,7-dichloroquinolines
provided the best yields of the mono- and diamination reaction products due to a difference in the
reactivity of the chlorine atoms. 2,8-Dichloroquinoline proved to be a more problematic substrate,
especially in the case of the diamination process, and the application of 2,6-dichloroquinoline led only
to complicated mixtures of unidentified products. The monoamination reactions were successfully
performed using 1 equiv. of the amine and BINAP as a ligand, while diamination processes demanded
the use of 3–4 equiv. of the amines and DavePhos ligand in the majority of cases. There was no
pronounced dependence of the yields of the monoamination products on the bulkiness of the amine
used, but the diamination processes were more successful for a less sterically hindered amine 1a
compared to the most hindered amine 1d.
Acknowledgments
This work was supported by the RFBR grant N 10-03-01108 and by the Russian Academy of
Sciences program “Elaboration of the methods for the synthesis of chemical compounds and
construction of new materials”.
References
1. Gilligan, B.S.; Veale, J.; Wodak, J. Amantadine hydrochloride in the treatment of Parkinson’s
Disease. Med. J. Aust. 1970, 2, 634–637.

Molecules 2013, 18
2107
2. Dolin, R.; Bentley, D.W. Options for the Control of Influenza. In Proceedings of the Viratek-UCLA
Symposium, Keystone, CO, USA, 20–25 April 1985; p. 317.
3. Svenson, T.N. Dopamine release and direct dopamine receptor activation in central nervous
system by D-145, an amantadine derivative. Eur. J. Pharmacol. 1973, 34, 232–238.
4. Da Settimo, A.; Marini, A.M.; Primofiore, G.; da Settimo, F. Synthesis and evaluation of
aminoadamantane derivatives for in vitro anti-HIV and antitumor activities. Farmacology 1995,
50, 321–326.
5. Ismail, F.M.D.; Dascombe, M.I.; Carrand, P.; North, S.E. An exploration of the structure-activity
relationships of 4-aminoquinolines: Novel antimalarials with activity in vivo. J. Pharm. Pharmacol.
1996, 48, 841–850.
6. Koert, G. Adamantylamino quinolines. U.S. Patent 3730956(A), 1 May 1973.
7. Aranyi, P.; Bata, I.; Batory, S.; Boronkay, E.; Bovy, P.; Kapui, Z.; Edit, S.; Szabo, T.;
Urban-Szabo, K.; Varga, M. New Compounds. WO 2005021536(A2), 10 March 2003.
8. Surry, D.S.; Buchwald, S.L. Dialkylbiaryl phosphines in Pd-catalyzed amination: A user’s guide.
Chem. Sci. 2011, 2, 27–50.
9. Surry, D.S.; Buchwald, S.L. Biaryl phosphane ligands in palladium-catalyzed amination.
Angew. Chem. Int. Ed. Engl. 2008, 47, 6338–6361.
10. Proutiere, F.; Aufiero, M.; Schoenebeck, F. Reactivity and stability of dinuclear Pd(I) complexes:
Studies on the active catalytic species, insights into precatalyst activation and deactivation, and
application in highly selective cross-coupling reactions. J. Am. Chem. Soc. 2012, 134, 606–612.
11. Hoi, K.H.; Çalimsiz, S.; Froese, R.D.J.; Hopkinson, A.C.; Organ, M.G. Amination with Pd-NHC
complexes: Rate and computational studies on the effects of the oxidative addition partner.
Chem. Eur. J. 2011, 17, 3086–3090.
12. Proutiere, F.; Schoenebeck, F. Solvent effect on palladium-catalyzed cross-coupling reactions and
implications on the active catalytic species. Angew. Chem. Int. Ed. Engl. 2011, 50, 8192–8195.
13. Jimeno, C.; Christmann, U.; Escudero-Adán, E.C.; Vilar, R.; Pericas, M.A. Studies on the
amination of aryl chlorides with a monoligated palladium catalyst: Kinetic evidence for a
cooperative mechanism. Chem. Eur. J. 2012, 18, 16510–16516.
14. Deraeve, C.; Maraval, A.; Vendier, L.; Faugeroux, V.; Pitié, M.; Meunier, B. Preparation of new
bis(8-aminoquinoline) ligands and comparison with bis(8-hydroxyquinoline) ligands on their
ability to chelate Cu(II) and Zn(II). Eur. J. Inorg. Chem. 2008, 2008, 5622–5631.
15. Lundgren, R.J.; Sappong-Kumankumah, A.; Stradiotto, M. A highly versatile catalyst system for
the cross-coupling of aryl chlorides and amines. Chem. Eur. J. 2010, 16, 1983–1991.
16. Michalik, D.; Kumar, K.; Zapf, A.; Tillack, A.; Arlt, M.; Heinrich, T.; Beller, M. A short and
efficient synthesis of N-aryl- and N-heteroaryl-N'-(arylalkyl)piperazines. Tetrahedron Lett. 2004,
45, 2057–2061.
17. Knight, R.L.; Allen, D.R.; Birch, H.L.; Chapman, G.A.; Galvin, F.C.; Jopling, L.A.; Lock, C.J.;
Meissner, J.W.; Owen, D.A.; Raphy, G.; et al. Development of CXCR3 antagonists. Part 4:
Discovery of 2-amino-(4-tropinyl)quinolines. Bioorg. Med. Chem. Lett. 2008, 18, 629–633.
18. Rataboul, F.; Zapf, A.; Jackstell, R.; Harkal, S.; Riermeier, T.; Monsees, A.; Dingerdissen, U.;
Beller, M. New ligands for a general palladium-catalyzed amination of aryl and heteroaryl
chlorides. Chem. Eur. J. 2004, 10, 2983–2990.

Molecules 2013, 18
2108
19. Navarro, O.; Marion, N.; Mei, J.; Nolan, P.S. Rapid room temperature Buchwald-Hartwig and
Suzuki-Miyaura couplings of heteroaromatic compounds employing low catalyst loadings.
Chem. Eur. J. 2006, 12, 5142–5148.
20. Anderson, K.W.; Tundel, R.E.; Ikawa, T.; Altman, R.A.; Buchwald, S.L. Monodentate phosphines
provide highly active catalysts for Pd-catalyzed C-N bond-forming reactions of heteroaromatic
halides/amines and (H)N-heterocycles. Angew. Chem. Int. Ed. Engl. 2006, 45, 6523–6527.
21. Berger, R.; Zhu, C.; Hansen, A.R.; Harper, B.; Chen, Z.; Holt, T.G.; Hubert, J.; Lee, S.J.; Pan, J.;
Qian, S.; et al. 2-Substituted piperazine-derived imidazole carboxamides as potent and selective
CCK1R agonists for the treatment of obesity. Bioorg. Med. Chem. Lett. 2008, 18, 4833–4837.
22. Nicolas, M.; Ecarnot, E.C.; Navarro, O.; Amoroso, D.; Bell, A.; Nolan, S.P. (IPr)Pd(acac)Cl: An
easily synthesized, efficient, and versatile precatalyst for C-N and C-C bond formation. J. Org. Chem.
2006, 71, 3816–3821.
23. Clayden, J.; Hennecke, U. α-Pyridylation of chiral amines via urea coupling, lithiation and
rearrangement. Org. Lett. 2008, 10, 3567–3570.
24. Tewari, A.; Hein, M.; Zapf, A.; Beller, M. Efficient palladium catalysts for the amination of aryl
chlorides: A comparative study on the use of phosphinum salts as precursors to bulky, electron-rich
phosphines. Tetrahedron 2005, 61, 9705–9709.
25. Organ, G.M.; Abdel-Hadi, M.; Avola, S.; Dubovyk, I.; Hadei, N.; Assen, B.; Kantchev, E.A.B.;
O’Brien, C.J.; Sayah, M.; Valente, C. Pd-catalyzed aryl amination mediated by well defined,
N-heterocyclic carbene (NHC)-Pd precatalysts, PEPPSI. Chem. Eur. J. 2008, 14, 2443–2452.
26. Serafinowska, H.T.; Blaney, F.E.; Lovell, P.J.; Merlo, G.G.; Scott, C.M.; Smith, P.W.; Starr, K.R.;
Watson, J.M. Novel 5-HT1A/1B/1D receptors antagonists with potent 5-HT reuptake inhibitory
activity. Bioorg. Med. Chem. Lett. 2008, 5581–5585.
27. Wang, T.; Magnin, D.R.; Hamann, L.G. Palladium-catalyzed microwave-assisted amination of
1-bromonaphthalenes and 5- and 8-bromoquinolines. Org. Lett. 2003, 5, 897–900.
28. Childers, W.E.; Havran, L.M.; Asselin, M.; Bicksler, J.J.; Chong, D.C.; Grosu, G.T.; Shen. Z.;
Abou-Gharbia, M.A.; Bach, A.C.; Harrison, B.L.; et al. The Synthesis and Biological Evaluation
of Quinolyl-piperazinyl Piperidines as Potent Serotonin 5-HT1A Antagonists. J. Med. Chem.
2010, 53, 4066–4084.
29. Xie, Y.-X.; Pi, S.-F.; Wang, J.; Yin, D.-L.; Li, J.-H. 2-Aminopyrimidine-4,6-diol as an efficient
ligand for solvent-free copper-catalyzed N-arylations of imidazoles with aryl and heteroaryl
halides. J. Org. Chem. 2006, 71, 8324–8327.
30. Klapars, A.; Antilla, J.; Huang, X.; Buchwald, S.L. A general and efficient copper catalyst for the
amidation of aryl halides and the N arylation of nitrogen heterocycles. J. Am. Chem. Soc. 2001,
123, 7727–7729.
31. Klapars, A.; Huang, X.; Buchwald, S.L. A general and efficient copper catalyst for the amidation
of aryl halides. J. Am. Chem. Soc. 2002, 124, 7421–7428.
32. Xie, J.; Ning, Z.; Tian, H. A soluble 5-carbazolium-8-hydroxyquinoline Al(III) complex as a
dipolar luminescent material. Tetrahedron Lett. 2005, 46, 8559–8562.
33. Wolf, C.; Lerebours, R. Use of highly active palladium-phosphinous acid catalysts in Stille, Heck,
amination, and thiation reactions of chloroquinolines. J. Org. Chem. 2003, 68, 7077–7084.

Molecules 2013, 18
2109
34. Melato, S.; Coghi, P.; Basilico, N.; Prosperi, D.; Monti, D. Novel 4-aminoquinolines through
microwave-assisted SNAr reactions: A practical route to antimalarial agents. Eur. J. Org. Chem.
2007, 2007, 6118–6123.
35. Girault, S.; Grellier, P.; Berecibar, A.; Maes, L.; Lemiere, P.; Mouray, E.; Davioud-Charvet, E.;
Sergheraert, C. Antiplasmodial activity and cytotoxicity of bis-, tris-, and tetraquinolines with
linear or cyclic amino linkers. J. Med. Chem. 2001, 44, 1658–1665.
36. Musonda, C.C.; Whitlock, G.A.; Witty, M.J.; Brun, R.; Kaiser, M. Chloroquine-astemizole
hybrids with potent in vitro and in vivo antiplasmodial activity. Bioorg. Med. Chem. Lett. 2009,
19, 481–484.
37. Averin, A.D.; Ulanovskaya, O.A.; Fedotenko, I.A.; Borisenko, A.A.; Serebryakova, M.V.;
Beletskaya, I.P. Palladium-catalysed amination of 3,5-dihalopyridines—A convenient route to
new polyazamacrocycles. Helv. Chim. Acta 2005, 88, 1983–2002.
38. Averin, A.D.; Ulanovskaya, O.A.; Pleshkova, N.A.; Borisenko, A.A.; Beletskaya, I.P. Pd-catalyzed
amination of 2,6-dihalopyridines with polyamines. Collect. Czech. Chem. Commun. 2007, 72,
785–819.
39. Averin, A.D.; Uglov, A.N.; Buryak, A.K.; Bessmertnykh, A.G.; Guilard, R.; Beletskaya, I.P.
Synthesis of polyazamacrocycles comprising 6,6'-diamino-2,2'-bipyridine moieties via Pd-catalyzed
amination. Heterocycles 2010, 80, 957–975.
40. Grigorova, O.K.; Averin, A.D.; Abel, A.S.; Maloshitskaya, O.A.; Kovalev, V.V.; Savelev, E.N.;
Orlinson, B.S.; Novakov, I.A.; Beletskaya, I.P. Arylation of adamantanamines: IV.
Palladium-catalyzed arylation of amines of adamantane series with chloroquinoline isomers.
Russ. J. Org. Chem. 2012, 48, 1391–1406.
41. Gopalan, B.; Thomas, A.; Shah, D.M. Preparation of adamantane derivatives as dipeptidyl
peptidase IV inhibitors, and pharmaceutical compositions containing them. WO 2006090244,
31 August 2006.
42. Novakov, I.A.; Kulev, I.A.; Radchenko, S.S.; Birznieks, K.A.; Boreko, E.I.; Vladyko, G.V.;
Korobchenko, L.V. Synthesis and antiviral activity of hydrochlorides of alicyclic mono- and
diamines. Pharm. Chem. J. 1987, 21, 454–458.
43. Averin, A.D.; Ranyuk, E.R.; Golub, S.L.; Buryak, A.K.; Savelyev, E.N.; Orlinson, B.S.;
Novakov, I.A.; Beletskaya, I.P. Synthesis of a new family of adamantylpyridin-2-amines via
Pd-catalyzed amination. Synthesis 2007, 2007, 2215–2221.
44. Ukai, T.; Kawazura, H.; Ishii, Y.; Bonnet, J.J.; Ibers, J.A. Chemistry of dibenzylideneacetone-
palladium(0) complexes I. Novel tris(dibenzylideneacetone)-dipalladium(solvent) complexes and
their reactions with quinines. J. Organomet. Chem. 1974, 65, 253–266.
Sample Availability: Not available.
© 2013 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article
distributed under the terms and conditions of the Creative Commons Attribution license
(http://creativecommons.org/licenses/by/3.0/).